HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.

Abstract
The promastigote surface antigen-2 (PSA-2) is a Leishmania parasite antigen, which can induce Th1-mediated protection against murine leishmaniasis when used as a vaccine. To evaluate PSA-2 as a human vaccine candidate the specific T-cell response to PSA-2 was characterised in individuals immune to cutaneous leishmaniasis. Peripheral blood mononuclear cells from Sudanese individuals with a past history of self-healing cutaneous leishmaniasis proliferated vigorously in response to PSA-2 isolated from Leishmania major, whereas the antigen did not activate cells from presumably unexposed Danes. Peripheral blood mononuclear cells from individuals with previous L. major infection had varying proliferative responses to PSA-2 derived from L. donovani promastigotes. Peripheral blood mononuclear cells activated by PSA-2 from L. major produced high amounts of interferon-gamma and tumour necrosis factor-beta, and little interleukin-4, thereby showing a Th1 cytokine pattern. Parallel cultures showed clear Th1 and Th2 response patterns to purified protein derivative of tuberculin or tetanus toxoid, respectively. Flow cytometric analysis revealed that PSA-2 induced blastogenesis in the CD3 positive population and that these cells were the major source of interferon-gamma. The results show that Th1-like cells recognising PSA-2 are expanded during infection by L. major and that they maintain their Th1-like cytokine profile upon reactivation in vitro. Since immunity to cutaneous leishmaniasis is mediated by antigen-specific Th1-like cells, PSA-2 might be considered a vaccine candidate for human leishmaniasis.
AuthorsM Kemp, E Handman, K Kemp, A Ismail, M D Mustafa, A Y Kordofani, K Bendtzen, A Kharazmi, T G Theander
JournalFEMS immunology and medical microbiology (FEMS Immunol Med Microbiol) Vol. 20 Issue 3 Pg. 209-18 (Mar 1998) ISSN: 0928-8244 [Print] England
PMID9566492 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Protozoan
  • Antigens, Surface
  • CD3 Complex
  • Lymphotoxin-alpha
  • Protozoan Proteins
  • Protozoan Vaccines
  • surface antigen P2, Leishmania
  • Interleukin-4
  • Interferon-gamma
Topics
  • Animals
  • Antigens, Protozoan (immunology)
  • Antigens, Surface (immunology)
  • CD3 Complex (analysis)
  • Flow Cytometry
  • Humans
  • Immunity, Active
  • Interferon-gamma (biosynthesis)
  • Interleukin-4 (biosynthesis)
  • Leishmania major (immunology)
  • Leishmaniasis, Cutaneous (immunology)
  • Leukocytes, Mononuclear (immunology)
  • Lymphocyte Activation
  • Lymphotoxin-alpha (biosynthesis)
  • Protozoan Proteins
  • Protozoan Vaccines (immunology)
  • Sudan
  • Th1 Cells (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: